Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

Palmar Hyperhidrosis Clinical Trial

Official title:
A Double-Blind, Randomized, Placebo-Controlled Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Moderate to Severe Palmar Hyperhidrosis

Status Completed

Clinical Trial Summary

This is a pilot exploratory study to evaluate the safety and efficacy of TC-5214 in subjects with palmar hyperhidrosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03404570
Study type	Interventional
Source	Atacama Therapeutics
Contact
Status	Completed
Phase	Phase 2
Start date	December 21, 2017
Completion date	January 18, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04906655` - An Open Label Study for Palmar Hyperhydrosis	Phase 2
Completed	`NCT03840655` - Fluorescent Thoracoscopy Used in Surgery for Palmar Hyperhidrosis
Completed	`NCT02321332` - Unilateral Sequential Sympathectomy for Palmar Hyperhidrosis	N/A
Active, not recruiting	`NCT04263623` - Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis	Phase 2
Completed	`NCT03880266` - A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis	Phase 2